Mississauga, Ontario, Oct. 26, 2017 – In recognition of Canadian Patient Safety Week (CPSW), occurring Oct. 30 – Nov.3, BD (Becton, Dickinson and Company), a leading global medical technology company, is joining the national effort to raise awareness of patient safety in Canada, with a specific focus on medication safety and patient empowerment.
It is estimated that patients experience preventable harm in one of every 18 hospitalizations, and up to 37 percent of these may be attributable to errors in the management of medications1. To help reduce and eliminate these occurrences, the theme for this year’s Canadian Patient Safety Week is Take with Questions – where patients are encouraged to ask questions and have an open dialogue with their health care provider about medication.
“BD - Canada is supporting patient safety by standing behind health care providers, to help improve the patient experience and patient outcomes,” says Anuj Pasrija, vice president, Market Access and Government Affairs for BD - Canada. “We believe that quality health care is a team effort. Both patients and health care workers benefit when health care workers are provided with the right tools and systems for quality care.”
Canadian Patient Safety Week is led by Canadian Patient Safety Institute (CPSI), an organization dedicated to advocating for safer health care practices across the nation. BD - Canada is supporting CPSI’s list of “5 questions to ask about your medications,” as well as encouraging health care providers in the workplace to be informed.
“Medication use is so common, and a fact of life for many people these days, that we were compelled to find better ways to keep people safe," said Chris Power, CEO, Canadian Patient Safety Institute. "We believe these five questions will bring much needed clarity to complex situations, and we encourage everyone to ask them in every care setting across Canada."
Canadian Patient Safety Week is an annual, nation-wide event, first launched in 2005. Canadians can join the conversation by using #asklistentalk.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com